Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions-Reference-Cited by-同舟云学术

Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions

Published:2021-08-01 Issue:4 Volume:6 Page:315-326
ISSN:2578-5125
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Stone Nicole L.¹,England Timothy J.¹²,O'Sullivan Saoirse E.²³

Affiliation:

1. Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, United Kingdom.

2. University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby, United Kingdom.

3. CanPharmaConsulting, Nottingham, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Link

https://www.liebertpub.com/doi/pdf/10.1089/can.2020.0159

Reference68 articles.

1. Structure and function of the blood–brain barrier

2. The Translational Significance of the Neurovascular Unit

3. Phenotypic Heterogeneity and Plasticity of Isocortical and Hippocampal Astrocytes in the Human Brain

4. The inflammatory response in stroke

5. Acute management of ischaemic stroke

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse;Cells;2024-08-24

2. Isobolographic Analysis of the Cytoprotective Effect of Dapsone and Cannabidiol Alone or Combination upon Oxygen–Glucose Deprivation/Reoxygenation Model in SH-SY5Y Cells;Antioxidants;2024-06-08

3. Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells;Archives of Toxicology;2024-05-15

4. A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders;Journal of Cannabis Research;2024-03-18

5. Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease;Handbook of Experimental Pharmacology;2024